Mutual of America Capital Management’s Kyntra Bio KYNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-2,710
Closed -$1.8M 1657
2021
Q2
$1.8M Sell
2,710
-117
-4% -$67.4K 0.02% 1005
2021
Q1
$2.45M Sell
2,827
-156
-5% -$166K 0.03% 877
2020
Q4
$2.77M Buy
2,983
+466
+19% +$490K 0.03% 779
2020
Q3
$2.59M Sell
2,517
-434
-15% -$467K 0.03% 695
2020
Q2
$2.99M Buy
2,951
+1,550
+111% +$1.44M 0.04% 610
2020
Q1
$1.22M Sell
1,401
-61
-4% -$60.6K 0.02% 912
2019
Q4
$1.57M Sell
1,462
-10
-0.7% -$10.2K 0.02% 1004
2019
Q3
$1.36M Sell
1,472
-9
-0.6% -$9.88K 0.02% 1004
2019
Q2
$1.67M Buy
1,481
+1
+0.1% +$1.09K 0.02% 949
2019
Q1
$2.01M Buy
1,480
+27
+2% +$36.6K 0.03% 863
2018
Q4
$1.68M Hold
1,453
0.03% 875
2018
Q3
$2.21M Sell
1,453
-10
-0.7% -$15.4K 0.03% 860
2018
Q2
$2.29M Buy
+1,463
New +$1.91M 0.03% 830

Other funds holding KYNB

Mutual of America Capital Management's KYNB Position: Q3 2021 in Review

Mutual of America Capital Management sold out of Kyntra Bio (KYNB) in Q3 2021, closing a stake of 2,710 shares — an estimated $1.8M sold.

Mutual of America Capital Management first reported a position in KYNB in Q2 2018 and held it in 13 quarters. The position peaked at $2.99M in Q2 2020. 164 funds tracked by Wall St. Rank hold KYNB as of Q3 2021.

  • Mutual of America Capital Management reported no remaining Kyntra Bio position as of Q3 2021 after selling out during the quarter.
  • Mutual of America Capital Management sold 2,710 Kyntra Bio shares in Q3 2021, an estimated $1.8M.
  • Mutual of America Capital Management first reported a position in Kyntra Bio in Q2 2018 and held it in 13 quarters.
  • Mutual of America Capital Management's Kyntra Bio position peaked at $2.99M in Q2 2020.
  • 164 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2021.

Based on Mutual of America Capital Management's 13F filing for Q3 2021, filed 10 Nov 2021.